Genomictree Inc. (KOSDAQ:228760)

Genomictree Statistics

Total Valuation

Genomictree has a market cap or net worth of KRW 472.41 billion. The enterprise value is 388.60 billion.

Market Cap	472.41B
Enterprise Value	388.60B

Important Dates

The next estimated earnings date is Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Genomictree has 24.02 million shares outstanding. The number of shares has increased by 3.29% in one year.

Current Share Class	24.02M
Shares Outstanding	24.02M
Shares Change (YoY)	+3.29%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	16.02%
Owned by Institutions (%)	0.25%
Float	20.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	132.87
PB Ratio	4.03
P/TBV Ratio	4.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-42.68
EV / Sales	109.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-27.17

Financial Position

The company has a current ratio of 19.20, with a Debt / Equity ratio of 0.02.

Current Ratio	19.20
Quick Ratio	18.97
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.16
Interest Coverage	-40.49

Financial Efficiency

Return on equity (ROE) is -7.51% and return on invested capital (ROIC) is -6.38%.

Return on Equity (ROE)	-7.51%
Return on Assets (ROA)	-6.13%
Return on Invested Capital (ROIC)	-6.38%
Return on Capital Employed (ROCE)	-10.74%
Revenue Per Employee	46.17M
Profits Per Employee	-118.24M
Employee Count	77
Asset Turnover	0.03
Inventory Turnover	7.95

Taxes

In the past 12 months, Genomictree has paid 1.09 million in taxes.

Income Tax	1.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.90% in the last 52 weeks. The beta is 0.12, so Genomictree's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	+25.90%
50-Day Moving Average	20,393.40
200-Day Moving Average	16,863.60
Relative Strength Index (RSI)	56.11
Average Volume (20 Days)	143,782

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genomictree had revenue of KRW 3.56 billion and -9.10 billion in losses. Loss per share was -379.45.

Revenue	3.56B
Gross Profit	502.29M
Operating Income	-12.77B
Pretax Income	-9.24B
Net Income	-9.10B
EBITDA	-11.65B
EBIT	-12.77B
Loss Per Share	-379.45

Balance Sheet

The company has 86.21 billion in cash and 2.22 billion in debt, giving a net cash position of 84.00 billion or 3,497.42 per share.

Cash & Cash Equivalents	86.21B
Total Debt	2.22B
Net Cash	84.00B
Net Cash Per Share	3,497.42
Equity (Book Value)	117.21B
Book Value Per Share	4,872.42
Working Capital	83.29B

Cash Flow

In the last 12 months, operating cash flow was -11.67 billion and capital expenditures -2.63 billion, giving a free cash flow of -14.30 billion.

Operating Cash Flow	-11.67B
Capital Expenditures	-2.63B
Free Cash Flow	-14.30B
FCF Per Share	-595.42

Margins

Gross margin is 14.13%, with operating and profit margins of -359.26% and -256.07%.

Gross Margin	14.13%
Operating Margin	-359.26%
Pretax Margin	-260.02%
Profit Margin	-256.07%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genomictree does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.29%
Shareholder Yield	-3.29%
Earnings Yield	-1.93%
FCF Yield	-3.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 14, 2018. It was a forward split with a ratio of 2.

Last Split Date	Sep 14, 2018
Split Type	Forward
Split Ratio	2

Scores

Genomictree has an Altman Z-Score of 39.7 and a Piotroski F-Score of 2.

Altman Z-Score	39.7
Piotroski F-Score	2